Treatment of Refractory Chronic Pruritus of Unknown Origin with Tofacitinib in Patients with Rheumatoid Arthritis

Fang Wang; Caroline Morris; Nancy D. Bodet; Brian S. Kim

doi:10.1001/jamadermatol.2019.2804

Treatment of Refractory Chronic Pruritus of Unknown Origin with Tofacitinib in Patients with Rheumatoid Arthritis

Fang Wang, Caroline Morris, Nancy D. Bodet, Brian S. Kim

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1426-1428
Number of pages	3
Journal	JAMA Dermatology
Volume	155
Issue number	12
DOIs	https://doi.org/10.1001/jamadermatol.2019.2804
State	Published - Dec 2019

Access to Document

10.1001/jamadermatol.2019.2804

Cite this

@article{7e4d367df1ab42028e36c78434d580c4,

title = "Treatment of Refractory Chronic Pruritus of Unknown Origin with Tofacitinib in Patients with Rheumatoid Arthritis",

author = "Fang Wang and Caroline Morris and Bodet, {Nancy D.} and Kim, {Brian S.}",

note = "Funding Information: Funding/Support: Research in the Kim lab is supported by the Doris Duke Charitable Foundation, Celgene Corporation, LEO Pharma, and the National Institute of Arthritis Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH K08AR065577 and R01AR070116).",

year = "2019",

month = dec,

doi = "10.1001/jamadermatol.2019.2804",

language = "English",

volume = "155",

pages = "1426--1428",

journal = "JAMA Dermatology",

issn = "2168-6068",

number = "12",

}

TY - JOUR

T1 - Treatment of Refractory Chronic Pruritus of Unknown Origin with Tofacitinib in Patients with Rheumatoid Arthritis

AU - Wang, Fang

AU - Morris, Caroline

AU - Bodet, Nancy D.

AU - Kim, Brian S.

N1 - Funding Information: Funding/Support: Research in the Kim lab is supported by the Doris Duke Charitable Foundation, Celgene Corporation, LEO Pharma, and the National Institute of Arthritis Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH K08AR065577 and R01AR070116).

PY - 2019/12

Y1 - 2019/12

UR - http://www.scopus.com/inward/record.url?scp=85072404655&partnerID=8YFLogxK

U2 - 10.1001/jamadermatol.2019.2804

DO - 10.1001/jamadermatol.2019.2804

M3 - Letter

C2 - 31532472

AN - SCOPUS:85072404655

SN - 2168-6068

VL - 155

SP - 1426

EP - 1428

JO - JAMA Dermatology

JF - JAMA Dermatology

IS - 12

ER -

Treatment of Refractory Chronic Pruritus of Unknown Origin with Tofacitinib in Patients with Rheumatoid Arthritis

Access to Document

Other files and links

Cite this